Triple negative breast cancer (TNBC) is more commonly diagnosed in younger and African-American women, is associated with worse recurrence-free survival and worse overall survival, and has fewer effective treatment options, compared to hormone receptor-positive or human epidermal growth factor receptor 2 (HER2)-positive breast cancer [1, 2]. Here, ERBB2 is linked to breast carcinoma.